Dark

Check out our Level2View

CDMO
Avid Bioservices, Inc. Common Stock
stock NASDAQ

Inactive

Feb 5, 2025 4:23:00 PM EST

12.49USD0.000%(0.00)3,047,628

Pre-market

0.00USD-100.000%(-12.48)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 10, 2022

08:05AM EST Avid Bioservices Announces Official Opening of Second Downstream GlobeNewswire Inc

Dec 8, 2021

10:33AM EST How Bad Are Avid Bioservices's Earnings? | Return On Capital Employed Benzinga

10:30AM EST Craig-Hallum Maintains Buy on Avid Bioservices, Raises Price Target to $35 Benzinga

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 Benzinga

09:04AM EST RBC Capital Maintains Outperform on Avid Bioservices, Raises Price Target to $32 Benzinga

04:32AM EST Keybanc Downgrades Avid Bioservices to Sector Weight Benzinga

Dec 7, 2021

05:09PM EST Avid Bioservices: Q2 Earnings Insights Benzinga

04:06PM EST Avid Bioservices Q2 EPS $0.06 Beats $0.02 Estimate Benzinga

04:05PM EST Avid Bioservices Reports Financial Results for Second Quarter GlobeNewswire Inc

03:57AM EST Earnings Scheduled For December 7, 2021 Benzinga

Dec 6, 2021

10:25AM EST Earnings Preview: Avid Bioservices Benzinga

Nov 30, 2021

04:05PM EST Avid Bioservices to Report Financial Results for Second Quarter of GlobeNewswire Inc

Nov 4, 2021

08:05AM EDT Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice GlobeNewswire Inc

Oct 26, 2021

10:56AM EDT Shares of biotechnology company Avid Bioservices, Inc. (CDMO) are rising 13 percent on Tuesday's trading after the company announced that it would be added to the S&P SmallCap 600 Index, effective before trading begins on Friday, October 29. RTTNews

08:22AM EDT Avid Bioservices PR Announces Co. To Join S&P SmallCap 600 Index; NOTE: News Was Initially Out Late Monday Benzinga

08:21AM EDT Avid Bioservices To Join S&P SmallCap 600 Index Benzinga

Oct 25, 2021

06:59PM EDT Avid Bioservices Set to Join S&P SmallCap 600 PR Newswire

05:17PM EDT Avid Bioservices Set To Join S&P SmallCap 600; Replaces Cadence Bancorp Benzinga

Oct 14, 2021

08:10AM EDT Avid Bioservices Announces Expansion Into Viral Vector Development And Manufacturing Services For Cell And Gene Therapy Benzinga

08:05AM EDT Leverages Established Track Record of Excellence in Biologics CGMP Manufacturing to Address the Rapidly Growing Cell and Gene Therapy Market GlobeNewswire Inc

Oct 7, 2021

08:13AM EDT Avid Bioservices Appoints Matthew Kwietniak As Chief Commercial Officer RTTNews

08:05AM EDT Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial GlobeNewswire Inc

Sep 8, 2021

04:11PM EDT Avid Bioservices Q1 EPS $0.10 Beats $0.04 Estimate, Sales $30.80M Beat $27.81M Estimate Benzinga

04:05PM EDT Avid Bioservices Reports Financial Results for First Quarter Ended GlobeNewswire Inc

04:04AM EDT Earnings Scheduled For September 8, 2021 Benzinga

Sep 2, 2021

04:05PM EDT Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that the company will participate in two upcoming investor conferences. GlobeNewswire Inc

Sep 1, 2021

04:05PM EDT Avid Bioservices to Report Financial Results for First Quarter of GlobeNewswire Inc

Jul 1, 2021

08:09AM EDT Avid Bioservices Appoints Esther Alegria To Board RTTNews

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

08:05AM EDT Avid Bioservices Announces Appointment of Esther M. Alegria, GlobeNewswire Inc

Jun 30, 2021

09:32AM EDT Craig-Hallum Maintains Buy on Avid Bioservices, Raises Price Target to $29 Benzinga

08:06AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

07:07AM EDT RBC Capital Maintains Outperform on Avid Bioservices, Raises Price Target to $27 Benzinga

04:40AM EDT Keybanc Maintains Overweight on Avid Bioservices, Raises Price Target to $28 Benzinga

Jun 29, 2021

05:29PM EDT Avid Biosciences Files For Potential Mixed Shelf Offering; Size Not Disclosed Benzinga

04:07PM EDT Avid Bioservices Sees FY22 Sales $115M-$117M Vs. $112.15M Est. Benzinga

04:07PM EDT Avid Bioservices Q4 EPS $(0.04) Up From $(0.11) YoY, Sales $27.61M Beat $21.60M Estimate Benzinga

04:05PM EDT -- Recorded Fourth Quarter Revenue of $27.6 Million and Annual Revenue of $95.9 Million -- GlobeNewswire Inc

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

04:01AM EDT Earnings Scheduled For June 29, 2021 Benzinga

Jun 24, 2021

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 22, 2021

04:05PM EDT Avid Bioservices to Report Financial Results For Quarter and GlobeNewswire Inc

May 25, 2021

08:05AM EDT Avid Bioservices to Serve as Commercial Manufacturer for ADC GlobeNewswire Inc

May 10, 2021

04:44PM EDT FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic Benzinga

Apr 15, 2021

04:05PM EDT Avid Bioservices Announces Completion of Redemption of Series E GlobeNewswire Inc

Mar 29, 2021

10:59AM EDT UPDATE: RBC Notes Avid Entered Current Good Manufacturing Practice Deal With Humanigen To Help Expand Production Capacity For Lenzilumab; RBC Notes Humanigen Data On Lenzilumab From Earlier Mon. Increases Chances Of Eventual FDA Approval Benzinga

10:54AM EDT Avid Biosciences, Humanigen Shares At New Session High As Traders Circulate Positive Commentary From RBC Capital Analyst Avid Shares Should Be Higher As A Sympathy Play Following Humanigen Data Benzinga

Mar 17, 2021

10:40AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2021 Benzinga

08:05AM EDT Avid Bioservices to Participate in KeyBanc Capital Markets Life GlobeNewswire Inc

07:14AM EDT RBC Capital Initiates Coverage On Avid Bioservices with Outperform Rating, Announces Price Target of $21 Benzinga

Mar 10, 2021

12:20AM EST Avid Bioservices, Inc. Announces Pricing of $125 Million Offering GlobeNewswire Inc

Mar 8, 2021

05:01PM EST Avid Bioservices, Inc. Announces Proposed $125 Million Offering of GlobeNewswire Inc

04:31PM EST Avid Bioservices: Q3 Earnings Insights Benzinga

04:11PM EST Avid Bioservices Raises Its FY21 Sales From $84M-$88M To $88M-$91m Vs $ 86.26M Estimates Benzinga

04:09PM EST Avid Bioservices Q3 EPS $0.01 Beats $(0.03) Estimate, Sales $21.80M Beat $19.07M Estimate Benzinga

04:05PM EST Avid Bioservices Reports Financial Results for Third Quarter GlobeNewswire Inc

04:05AM EST Earnings Scheduled For March 8, 2021 Benzinga

Mar 3, 2021

04:05PM EST Avid Bioservices Declares Quarterly Dividend on Its Series E GlobeNewswire Inc

Mar 1, 2021

04:05PM EST Avid Bioservices to Report Financial Results for Third Quarter of GlobeNewswire Inc

Feb 22, 2021

08:12AM EST Avid Bioservices Highlights Beginning Of Phase 2 Of Its Myford Manufacturing Capacity Expansion Plan Benzinga

08:08AM EST Avid Bioservices Initiates Phase 2 Of Its Myford Manufacturing Capacity Expansion Plan RTTNews

08:05AM EST Build Out of Myford Facility Will Expand Current Footprint to Include Second Manufacturing Train with Both Upstream and Downstream Processing Suites GlobeNewswire Inc

Feb 3, 2021

07:02AM EST Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement For COVID-19 Therapeutic Candidate Lenzilumab In Support Of Potential EUA Filing Benzinga

07:00AM EST Humanigen and Avid Bioservices Enter into cGMP Manufacturing GlobeNewswire Inc

Dec 14, 2020

04:05PM EST Avid Bioservices Announces Closing of Public Offering of Common Stock GlobeNewswire Inc

Dec 10, 2020

09:01AM EST Avid Bioservices Announces Pricing Of 3,333,335 Shares Of Stock At $9/Share Benzinga

09:00AM EST Avid Bioservices Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc

Dec 9, 2020

04:49PM EST Avid Bioservices Announces Proposed Public Offering Of Common Stock; Size Not Disclosed Benzinga

04:45PM EST Avid Bioservices Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

Dec 7, 2020

04:05PM EST Avid Bioservices Announces Appointment of Jeanne Thoma to Board of GlobeNewswire Inc

Dec 2, 2020

04:05PM EST Avid Bioservices Reports Financial Results for Second Quarter GlobeNewswire Inc

04:06AM EST Earnings Scheduled For December 2, 2020 Benzinga

Dec 1, 2020

04:05PM EST Avid Bioservices Declares Quarterly Dividend on Its Series E GlobeNewswire Inc

Nov 24, 2020

04:05PM EST Avid Bioservices to Report Financial Results for Second Quarter of GlobeNewswire Inc

Sep 15, 2020

04:05PM EDT Avid Bioservices Announces Move to Virtual-Only Annual Meeting of GlobeNewswire Inc

Sep 2, 2020

11:45AM EDT Avid Bioservices shares are trading higher after the company reported better-than-expected Q1 EPS and sales results on Tuesday. The company also confirmed FY21 sales guidance. Benzinga

Sep 1, 2020

04:18PM EDT Recap: Avid Bioservices Q1 Earnings Benzinga

04:07PM EDT Avid Bioservices Confirms FY21 Sales Guidance Of $76M-$81M vs $78.96M Est. Benzinga

04:06PM EDT Avid Bioservices Q1 EPS $0.06 Beats $(0.07) Estimate, Sales $25.40M Beat $16.50M Estimate Benzinga

04:05PM EDT Avid Bioservices Reports Financial Results for First Quarter Ended GlobeNewswire Inc

Aug 31, 2020

04:05PM EDT Avid Bioservices Declares Quarterly Dividend on Its Series E GlobeNewswire Inc

10:15AM EDT Avid Bioservices Earnings Preview Benzinga

Aug 30, 2020

08:24AM EDT The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing Benzinga

Aug 26, 2020

08:11AM EDT Avid Bioservices Selected By Mapp Biopharmaceutical, Inc. For Clinical Development Of Novel Human Monoclonal Antiviral Antibody Benzinga

08:05AM EDT Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for GlobeNewswire Inc

Aug 25, 2020

04:05PM EDT Avid Bioservices to Report Financial Results for First Quarter of GlobeNewswire Inc

Aug 20, 2020

08:37AM EDT Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine Benzinga

08:33AM EDT Oragenics And Avid Bioservices Enter Process Development And drug Substance Manufacturing Agreement RTTNews

08:30AM EDT Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine Business Wire

Aug 6, 2020

08:09AM EDT Avid Biosciences Reports Selected By Iovance Biotherapeutics To Lead Process Development Through CGMP Manufacturing Of IOV-3001 Benzinga

Jul 28, 2020

08:43AM EDT Avid Bioservices, Argonaut Manufacturing Services Announce Co-marketing Agreement RTTNews

08:08AM EDT Avid Bioservices And Argonaut Manufacturing Services Enter Agreement To Offer Biotechnology And Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing And Drug Product Parenteral Manufacturing Benzinga

08:05AM EDT Avid Bioservices and Argonaut Manufacturing Services Enter GlobeNewswire Inc

Share